Compare Abbott Laboratories (ABT) vs United States Copper Index Fund (CPER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abbott Laboratories vs United States Copper Index Fund — how do they compare? Abbott Laboratories trades at $110.54 (market cap $187.95B), while United States Copper Index Fund trades at $39.78. The key difference: Abbott Laboratories pays a 2.32% dividend while United States Copper Index Fund pays none, and United States Copper Index Fund is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | CPER | |
|---|---|---|
Market Cap | $187.95B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $136.62 | $40.85 |
52-Week Low | $82.57 | $27.57 |
Enterprise Value | $214.96B | — |
Dividend Yield | 2.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $108.63, up 0.77% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $44.33B in 2025 with a net income margin of 11.65%, while recent Q1 and Q2 2026 earnings beat expectations. The company maintains solid cash flow from operations of $9.57B and recently secured CE Mark for innovative dual glucose-ketone sensors, reinforcing its healthcare leadership.
Outlook remains positive with a consensus price target of $120.70, implying 11% upside, supported by 75.6% analyst buy ratings. Key risks include competitive pressures in diagnostics and macroeconomic sensitivity. The dividend yield and innovation pipeline offer stability, but investors should monitor execution on growth initiatives amid evolving market conditions.
CPER, tracking copper futures, trades at $40.02, down 0.4% on the day. The technical outlook is bullish with strong moving average signals, though RSI levels suggest potential overbought conditions. Recent news highlights copper hitting record highs driven by AI infrastructure demand and supply disruptions in Chile, per CNBC on August 6, 2026. Financial ratios are not applicable as CPER is an ETF.
The outlook for CPER is positive due to structural copper demand from electrification and AI, but risks include price volatility from geopolitical tensions and substitution threats. Analyst sentiment is constructive given supply constraints, though investors face commodity-specific cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About United States Copper Index Fund
CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.
Read more on CPER →
